Skip to main content
Article

Commensal Gut Bacteria Convert the Immunosuppressant Tacrolimus to Less Potent Metabolites

Yukuang GuoDepartments of Medicinal Chemistry and Pharmacognosy (Y.G., C.M.C., J.O., H.L.), Pharmacy Practice (K.-J.W., H.J.), Biopharmaceutical Sciences (X.Y., H.J.), and Center for Biomolecular Sciences (Y.G., J.O., H.L., H.J.), University of Illinois at Chicago, Chicago, Illinois; and Division of Nephrology and Hypertension, Department of Medicine, Weill Cornell Medicine, New York, New York (J.R.L.)Camila Manoel CrnkovicDepartments of Medicinal Chemistry and Pharmacognosy (Y.G., C.M.C., J.O., H.L.), Pharmacy Practice (K.-J.W., H.J.), Biopharmaceutical Sciences (X.Y., H.J.), and Center for Biomolecular Sciences (Y.G., J.O., H.L., H.J.), University of Illinois at Chicago, Chicago, Illinois; and Division of Nephrology and Hypertension, Department of Medicine, Weill Cornell Medicine, New York, New York (J.R.L.)Kyoung‐Jae WonDepartments of Medicinal Chemistry and Pharmacognosy (Y.G., C.M.C., J.O., H.L.), Pharmacy Practice (K.-J.W., H.J.), Biopharmaceutical Sciences (X.Y., H.J.), and Center for Biomolecular Sciences (Y.G., J.O., H.L., H.J.), University of Illinois at Chicago, Chicago, Illinois; and Division of Nephrology and Hypertension, Department of Medicine, Weill Cornell Medicine, New York, New York (J.R.L.)Xiaotong YangDepartments of Medicinal Chemistry and Pharmacognosy (Y.G., C.M.C., J.O., H.L.), Pharmacy Practice (K.-J.W., H.J.), Biopharmaceutical Sciences (X.Y., H.J.), and Center for Biomolecular Sciences (Y.G., J.O., H.L., H.J.), University of Illinois at Chicago, Chicago, Illinois; and Division of Nephrology and Hypertension, Department of Medicine, Weill Cornell Medicine, New York, New York (J.R.L.)John R. LeeDepartments of Medicinal Chemistry and Pharmacognosy (Y.G., C.M.C., J.O., H.L.), Pharmacy Practice (K.-J.W., H.J.), Biopharmaceutical Sciences (X.Y., H.J.), and Center for Biomolecular Sciences (Y.G., J.O., H.L., H.J.), University of Illinois at Chicago, Chicago, Illinois; and Division of Nephrology and Hypertension, Department of Medicine, Weill Cornell Medicine, New York, New York (J.R.L.)Jimmy OrjalaDepartments of Medicinal Chemistry and Pharmacognosy (Y.G., C.M.C., J.O., H.L.), Pharmacy Practice (K.-J.W., H.J.), Biopharmaceutical Sciences (X.Y., H.J.), and Center for Biomolecular Sciences (Y.G., J.O., H.L., H.J.), University of Illinois at Chicago, Chicago, Illinois; and Division of Nephrology and Hypertension, Department of Medicine, Weill Cornell Medicine, New York, New York (J.R.L.) [email protected] [email protected] [email protected]Hyunwoo LeeDepartments of Medicinal Chemistry and Pharmacognosy (Y.G., C.M.C., J.O., H.L.), Pharmacy Practice (K.-J.W., H.J.), Biopharmaceutical Sciences (X.Y., H.J.), and Center for Biomolecular Sciences (Y.G., J.O., H.L., H.J.), University of Illinois at Chicago, Chicago, Illinois; and Division of Nephrology and Hypertension, Department of Medicine, Weill Cornell Medicine, New York, New York (J.R.L.) [email protected] [email protected] [email protected]Hyunyoung JeongDepartments of Medicinal Chemistry and Pharmacognosy (Y.G., C.M.C., J.O., H.L.), Pharmacy Practice (K.-J.W., H.J.), Biopharmaceutical Sciences (X.Y., H.J.), and Center for Biomolecular Sciences (Y.G., J.O., H.L., H.J.), University of Illinois at Chicago, Chicago, Illinois; and Division of Nephrology and Hypertension, Department of Medicine, Weill Cornell Medicine, New York, New York (J.R.L.) [email protected] [email protected] [email protected]
2018en
ABI

Abstract

No abstract available.

Identifiers

Citations and references

Cited by 20 references